For: | Sahra S, Abureesh M, Amarnath S, Alkhayyat M, Badran R, Jahangir A, Gumaste V. Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United States. World J Hepatol 2021; 13(8): 926-938 [PMID: 34552699 DOI: 10.4254/wjh.v13.i8.926] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/926.htm |
Number | Citing Articles |
1 |
Yuanbin Liu, Mingkai Chen, Armand Abergel. Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4209442
|
2 |
Yana V Kiseleva, Roman V Maslennikov, Aida N Gadzhiakhmedova, Tatyana S Zharikova, Dmitry V Kalinin, Yury O Zharikov. <i>Clostridioides difficile</i> infection in patients with nonalcoholic fatty liver disease-current status. World Journal of Hepatology 2023; 15(2): 208-215 doi: 10.4254/wjh.v15.i2.208
|
3 |
Jennifer Eeuwijk, Gui Ferreira, Juan Pablo Yarzabal, Mirna Robert-Du Ry van Beest Holle. A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States. Infectious Diseases and Therapy 2024; 13(2): 273 doi: 10.1007/s40121-024-00919-0
|
4 |
Rehmat Ullah Awan, Karthik Gangu, Anthony Nguyen, Prabal Chourasia, Oscar F. Borja Montes, Muhammad Ali Butt, Taimur Sohail Muzammil, Rao Mujtaba Afzal, Ambreen Nabeel, Rahul Shekhar, Abu Baker Sheikh. COVID-19 and Clostridioides difficile Coinfection Outcomes among Hospitalized Patients in the United States: An Insight from National Inpatient Database. Infectious Disease Reports 2023; 15(3): 279 doi: 10.3390/idr15030028
|
5 |
Ankoor H. Patel, Gaurav N. Pathak, Alexander Chen, Patricia Greenberg, Natale Mazzaferro, Anish Patel, Naveen Mallangada, Carlos D. Minacapelli, Kaitlyn Catalano, Hansel Suthar, Vinod K. Rustgi. Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH. Annals of Hepatology 2024; 29(4): 101510 doi: 10.1016/j.aohep.2024.101510
|